title: Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.
authors.affiliation: Office of Scientific Affairs, American Heart Association, Dallas, TX 75231.
authors.forename: A L
authors.initials: AL
authors.lastname: Bisno
authors.forename: W E
authors.initials: WE
authors.lastname: Dismukes
authors.forename: D T
authors.initials: DT
authors.lastname: Durack
authors.forename: E L
authors.initials: EL
authors.lastname: Kaplan
authors.forename: A W
authors.initials: AW
authors.lastname: Karchmer
authors.forename: D
authors.initials: D
authors.lastname: Kaye
authors.forename: S H
authors.initials: SH
authors.lastname: Rahimtoola
authors.forename: M A
authors.initials: MA
authors.lastname: Sande
authors.forename: J P
authors.initials: JP
authors.lastname: Sanford
authors.forename: C
authors.initials: C
authors.lastname: Watanakunakorn
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D010403:Penicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000145:classification
chemical_list: D000900:Anti-Bacterial Agents